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第 1表 Kuppermanの MenopausalIndex
と同様,下記の3項目につき検討した.
i)更年期指数 (MenopausaHndex)1953

























与 前 l 単 独 投 与 后 併 用 投 与 后





投 与 前 日 単 独 投 与 后 日 併 用 投 与 后
第1図 A群の治療前后のM.I.の変化 第2図 B群の治療前后のM.Ⅰ.の変化


















































50 熊 本 寛 格
によって,不安定な時期と可成 り安定した時 い難い.
期がある (発表予定)ので, この点も考慮す 〔≠〕血清総コレステロ-ル値に就いて
る必要があり,現段階では断定的なことは言 A.B両群に於ける治療前後の血清総コレ












































































































































































































SOME CLINICAL OBSERVATIONS ON THE MENOPAUSAL
SYNDROME AND ITS THERAPEUTIC APPROACH
by
Hirotada KUMAMOTO, M. D.
Institute for Thermal Spring Research Okayama University,
Misasa, Tottori-ken, Japan.
In order to observe the effectiveness of the androgen+estrogen therapy used
singly or in combination with the meprobamate therapy, the author has determined
the menopausal index, the total serum cholesterol and the systolic blood pressure
before and after the administration of these treatments.
The following results have been obtained.
1) The menopausal index (Kupperman, 1953) declines more markedly fol1owing the
application of the combined therapies than after the use of either, administered
singly.
2) Total serum cholesterol decreases most pronouncedly following the use of the
combined therapies, to a lesser degree following the administration of A+E, still
less following a single administration of meprobamate. It has been found, moreover,
that although A +E therapy appreciably decreases total serum cholesterol, the
effectiveness of meprobamate is slight in this respect.
3) Either therapy tends to stabilize blood pressure, but the combined treatment is
more effective in this regard.
It may safely be concluded that the use of these therapies singly or combined,
will provide one of the most effective therapeutic approaches to the menopausal
syndrome, the more especially so because of the absence of side effects, an important
consideration when long term treatment, required in most such cases, is contemplated.
